In patients with central venous catheters (CVCs), catheter-related bloodstream infections (CRBI) are a prominent cause of morbidity, excess hospital costs, and in some cases mortality. The aim of this prospective study was to assess the validity of the Gram stain-acridine orange leukocyte cytospin (AOLC) test for the diagnosis of CRBI in hematopoietic stem cell transplant (HSCT) recipients with nontunnelled CVCs, using the differentialtime-to-positivity (DTP)/clinical criteria as the criterion standard to define CRBIs. CVCs were externalized, nontunnelled, polyurethane double lumen catheters (Arrows, Readings, USA). All CVCs were placed in the subclavian vein by the infraclavicular approach, in the operating room. Catheters were inserted percutaneously, using the Seldinger technique. Study catheters were not exchanged over guidewires. Between May 2002 and December 2004, a total of 245 consecutive patients were included. Twenty-six of the 245 patients (10.6%) had CRBI as determined by the DTP method. The Gram stain-AOLC was positive in only two patients (7.6%) with a CRBI. Our results suggest that the Gram stain-AOLC test is not useful for the diagnosis of catheterrelated bloodstream infection in HSCT recipients.
Introduction
Central venous catheters (CVCs) are commonly used in hematopoietic stem cell transplant (HSCT) recipients for indications, such as monitoring of hemodynamics and administration of blood products, chemotherapy, parenteral nutrition, and fluids. [1] [2] [3] Data from the National Nosocomial Infection Surveillance (NNIS) system (US) between January 1992 and February 1998 showed that catheter-related bloodstream infection (CRBI) was the third most frequent nosocomial infection and accounted for 14% of all nosocomial infections. 4 CRBIs prolong hospital stays from 7 to 21 days and account for an estimated increase in hospital costs of $ 3000-40 000 per patient. [5] [6] [7] In addition, an estimated 10-20% attributable mortality owing to nosocomial CRBI has been reported. 6 Only 20% of CVCs removed because of suspected infection actually prove to be infected, and the diagnosis is always retrospective. [8] [9] [10] Recently, it has been shown that CRBIs can be detected by the Gram stain and acridine orange leukocyte cytospin (AOLC) test 11 or the differential-time-to-positivity (DTP) method, without catheter removal. 12, 13 The aim of the present prospective study was to assess the validity of the Gram stain-AOLC test for the diagnosis of CRBI in HSCT recipients with nontunnelled CVCs, using the DTP/clinical criteria as the criterion standard to define CRBIs.
Materials and methods

Study design
This prospective study was conducted between May 2002 and December 2004 at the 'National Centre for Bone Marrow Transplantation', Tunisia. This study was approved by the hospital ethics committee and written consent was obtained from the patients or their legal representatives.
Patients were eligible for the study if they were between 4 and 60 years of age, and required a HSCT for treatment of a hematologic malignancy. They also had to have neutropenia (absolute neutrophil count of o500/ml), a nontunnelled CVC in place, and fever as defined previously. 14 Exclusion criteria were the presence of a CVC at admission, catheterization for o7 days, and a contraindication to the use of subclavian catheterization due to a major blood coagulation disorder (i.e., platelet count o50 Â 10 9 /l, disseminated intravascular coagulation).
CVCs were externalized, nontunnelled, polyurethane double lumen catheters (Arrows, Readings, USA). Catheter sizes were chosen appropriate to age (5 or 7 French diameter). The inserting physician wore mask, cap, sterile gloves, and a surgical gown and used large sterile drapes. The skin insertion site was disinfected with povidone iodine. All CVCs were placed in the subclavian vein by the infraclavicular approach, by the same physician in the operating room. Catheters were inserted percutaneously, using the Seldinger technique. 15 The CVC tip was confirmed radiographically to lie in the superior vena cava. Study catheters were not exchanged over guidewires. Insertion sites were covered with a transparent sterile dressing (Tegaderm, Healthcare, USA). Catheter care included changing of the dressing under aseptic conditions every 6 days.
Microbiologic methods
The following tests were undertaken immediately after onset of fever in all patients: a 1-ml sample of blood (treated with EDTA) was drawn from every lumen of the catheter for Gram stain and the AOLC test as previously described. 16 A 50-ml sample of EDTA-treated catheter blood was added to 10% vol formalin saline solution for 2 min. After saline was added, the sample was centrifuged, the supernatant decanted, and the cellular deposit homogenized and cytocentrifuged. A monolayer was placed on a microscope slide, heat-dried, and stained with 1 in 10 000 (wt/vol) with acridine orange staining, and viewed by ultraviolet light. All samples were prepared by the same technician. Two control slides for each preparation were prepared starting from an ATCC 25922 Escherichia coli and ATCC 25923 Staphylococcus aureus strains 10 4 and 10 5 CFU/ml dilution in defibrinated sheep blood. All AOLC and Gram stains were evaluated by the same two technicians. Patient blood (10 ml) and 10 ml of control samples were directly plated on blood agar and chocolate agar and incubated. Sterility control of EDTA was successfully performed.
Afterwards, blood was drawn simultaneously through every lumen of the catheter for one pair of aerobic and anaerobic blood culture bottles each (hub-blood culture) and through a peripheral vein for an additional pair of aerobic and anaerobic blood culture bottles. EDTA-blood samples and blood cultures were processed, and the DTP was calculated and expressed as previously described. 17 The identity of isolates from peripheral and CVC positive blood cultures was assessed on the basis of colony morphology, species identification, and identical antibiogram. Catheters were removed aseptically, at the discretion of primary care physicians, if they were no longer needed or if infection was suspected. A 5-cm segment of the removed catheter tip was aseptically cut and delivered to the microbiology laboratory for quantitative culture according to Brun-Buisson et al. 8 To determine any relation of coagulase-negative Staphylococci (CNS) derived from peripheral blood cultures, hub-blood cultures, Gram stain and AOLC control cultures, and Brun-Buisson cultures, pulsed-field gel electrophoresis (PFGE) was performed using standard methods with minor modifications. 18, 19 CRBI was defined according to Infectious Disease Society of America guidelines 20 as bacteremia or fungemia in a patient who has an intravascular device and X1 positive result of culture of blood samples obtained from the peripheral vein, clinical manifestations of infection (e.g., fever, chills, and/or hypotension), no apparent source for bloodstream infection (with the exception of the catheter), and a positive DTP result (X120 min).
Data collection
Standardized data collection forms were completed for all patients. These data included demographic characteristics, underlying disease, therapy, catheter insertion and removal date, and mechanical complications.
Additional data recorded were the presence of local signs and symptoms of infection at the catheter insertion site (e.g., swelling, warmth, tenderness, or purulent discharge), duration of fever, neutrophil count on day of insertion, and duration of neutropenia.
Results
A total of 245 consecutive patients (125 males and 120 females; median age: 30 years (4-59 years)) were included during the 32-month study period. Twenty-six of the 245 patients (10.6%) had CRBI as determined by the DTP method. The main characteristics of the 26 patients are shown in Table 1 . The median number of days between insertion of the CVC and diagnosis was 26 (10-35 days). In Table 1 Characteristics of patients with CRBI Gram stain-acridine orange leukocyte cytospin test A Abdelkefi et al two of 26 patients (7.6%) with a positive DTP result, the Gram stain-AOLC was positive (Table 2) , providing a positive and negative predictive value of 9 and 89%, respectively. Microorganisms involved in CRBI were: CNS (n ¼ 16), Candida albicans (n ¼ 2), Pseudomonas aeruginosa (n ¼ 2), and S. aureus, Klebsiella oxytoca, Enterobacter cloacae, E. coli, Stenotrophomonas maltophilia, Corynebacterium spp (one case respectively). Only one death (S. maltophilia) was attributed to CRBI.
In patients with CNS CRBI, CNS strains from corresponding cultures had identical PFGE patterns, indicating that the positive results from these methods (e.g., DTP and Gram stain-AOLC and its control culture and BrunBuisson method) were due to the same strain.
The CVC was removed in all patients with CRBI, and appropriate systemic antimicrobial therapy was administered. Choice and duration of antimicrobial therapy depended on the pathogen isolated, the resistance pattern, and the presence of complications, such as deep-seated infections.
Discussion
The clinical diagnosis of CRBI lacks accuracy; when infection is suspected, a confident diagnosis requires removal of the CVC, whereas failure to make the diagnosis may have serious consequences. Most of the CVCs removed on clinical ground are not infected on subsequent culture. 21, 22 Withdrawal of the catheter and replacement with a new catheter increases costs and is associated with an increased risk of mechanical complications. 23, 24 The Gram stain-AOLC test, which detects bacteria from a small quantity of catheter blood, can be performed in o1 h, unlike quantitative cultures, thus making it a potentially viable method for rapidly detecting an infected catheter in situ.
To our knowledge, this is the largest prospective study (245 patients) performed to assess the validity of Gram stain-AOLC test for the diagnosis of CRBI in HSCT recipients with nontunnelled CVCs using the DTP/clinical criteria as the criterion standard to define CRBIs. Twentysix of the 245 patients (10.6%) had CRBI as determined by the DTP method. In only two of 26 patients (7.6%) with a positive DTP result was the Gram stain-AOLC positive, providing a positive and negative predictive value of 9 and 89% respectively. Our results suggest that the Gram stain-AOLC test is not useful for the diagnosis of CRBI in HSCT recipients.
In contrast, a recent study in neutropenic patients showed that the Gram-stain-AOLC test had a lower sensitivity than did the DTP method but acceptable positive and negative predictive values.
11 Fifty-one patients were included in this study. Thirty-two had a CVC without a subcutaneous tunnel, two had a tunnelled CVC, and 17 had totally implanted CVCs (Port-A-Caths). In 11 of 16 patients (69%) with a positive DTP result, the Gram stain-AOLC test was positive, providing a positive and negative predictive value of 100 and 88%, respectively.
Seven studies 16, [25] [26] [27] [28] [29] [30] have been performed to assess the validity of the Gram stain-AOLC test for the diagnosis of CRBI in non-neutropenic patients. Rushforth et al., 25 in an infant population, found the test 87% sensitive and 94% specific in the diagnosis of central catheter-related sepsis, as defined by quantitative blood culture. More recently, Tighe 25 Kite et al. 16 reported superior sensitivity and specificity of Gram stain-AOLC test for the diagnosis of CRBI in comparison with three other conventional methods: roll-plate, CVC-tip flush, and endoluminal brush. In a recent study, Bong et al. 27 have demonstrated that a policy of selective removal of catheters based on the AOLC test was safe, feasible, and cost effective.
In contrast, Gowardman et al. 28 in a cohort of 400 patients, demonstrated that in the 12 patients with CRBI the AOLC test was negative in all cases. They concluded that the AOLC test used alone was unhelpful as a method of diagnosing in situ CVC infection, consistent with the findings of Tighe et al., 26 but in sharp contrast to those reported by Rushforth et al. 25 Recently, Farina et al.
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showed in a pediatric population that the AOLC test did not aid diagnosis of CRBI.
In our study, we found the AOLC test to be labour intensive and demanding of skilled personnel for accurate performance and interpretation. Our results suggest that the Gram stain-AOLC test is not useful for the diagnosis of CRBI in HSCT recipients.
In conclusion, based on our findings, we cannot recommend the routine adoption of the Gram-stain-AOLC test as the first line investigation of CRBI in neutropenic patients.
